glp 1 and alcohol GLP-1s Hold Promise as Treatment for Use Disorder GLP1 receptor agonists are supported
Description
Cognitive and behavioral problems might also manifest
doi: 10.1001/JAMAINTERNMED.2023.6663 92 DaoKShechtmanSWeber-SchoendorferCDiav-CitrinOMuradRHBerlinMet al

The semaglutide group were significantly less likely to experience MACE

Non-Pharmaceutical Options Lifestyle interventions Structured diet plans, regular physical activity, and behavioural therapy
Treatment S1 meal type S2 meal type: t 50.4 = 3.50, p = 0.001)

Most insurance companies require a BMI measurement documented within the past 3-6 months as part of the prior authorization process
